Ventas, Inc. Stock

Equities

VTR

US92276F1003

Specialized REITs

Real-time Estimate Cboe BZX 03:33:04 2024-06-07 pm EDT 5-day change 1st Jan Change
49.58 USD -0.53% Intraday chart for Ventas, Inc. -1.47% -0.64%
Sales 2024 * 4.84B Sales 2025 * 5.12B Capitalization 20.14B
Net income 2024 * 3M Net income 2025 * 115M EV / Sales 2024 * 6.83 x
Net Debt 2024 * 12.89B Net Debt 2025 * 12.86B EV / Sales 2025 * 6.44 x
P/E ratio 2024 *
1,007 x
P/E ratio 2025 *
190 x
Employees 486
Yield 2024 *
3.65%
Yield 2025 *
3.83%
Free-Float 99.39%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.14%
1 week+1.71%
Current month-0.84%
1 month+5.93%
3 months+14.73%
6 months+8.21%
More quotes
1 week
49.48
Extreme 49.48
50.49
1 month
46.66
Extreme 46.66
50.49
Current year
41.45
Extreme 41.45
50.61
1 year
39.33
Extreme 39.33
50.99
3 years
35.33
Extreme 35.33
64.02
5 years
13.35
Extreme 13.345
75.40
10 years
13.35
Extreme 13.345
81.93
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 98-12-31
Director of Finance/CFO 56 14-10-26
Chief Tech/Sci/R&D Officer - 19-01-24
Members of the board TitleAgeSince
Director/Board Member 60 22-03-06
Director/Board Member 63 11-05-11
Director/Board Member 55 20-07-05
More insiders
Date Price Change Volume
24-06-07 49.52 -0.64% 662 849
24-06-06 49.84 +0.14% 1,808,603
24-06-05 49.77 -0.46% 2,122,489
24-06-04 50 -0.06% 2,295,887
24-06-03 50.03 -0.46% 3,321,845

Delayed Quote Nyse, June 06, 2024 at 04:00 pm EDT

More quotes
Ventas, Inc. specializes in owning and managing healthcare and medical-residential facilities. At the end of 2022, the group's portfolio included 1,237 assets consisting primarily of senior housing (802), medical office buildings (313), rehabilitation and long-term acute care facilities (36), laboratories and research facilities (32), skilled nursing facilities (16), medical and surgical facilities (13). Net sales are distributed geographically as follows: the United States (88.5%), Canada (10.9%) and the United Kingdom (0.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
49.84 USD
Average target price
53.51 USD
Spread / Average Target
+7.37%
Consensus